Scutellaria baicalensis Georgi Extracts inhibit RANKL-induced Osteoclast Differentiation

  • Shim, Ki-Shuk (Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology) ;
  • Kim, Soon-Nam (Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology) ;
  • Kim, Myung-Hee (Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology, Department of Biochemistry, Chungnam National University) ;
  • Kim, Young-Sup (Laboratory of Phytochemistry Research, Korea Research Institute of Chemical Technology) ;
  • Ryu, Shi-Yong (Laboratory of Phytochemistry Research, Korea Research Institute of Chemical Technology) ;
  • Min, Yong-Ki (Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology) ;
  • Kim, Seong-Hwan (Laboratory of Chemical Genomics, Korea Research Institute of Chemical Technology)
  • Published : 2008.09.30

Abstract

Scutellaria baicalensis Georgi (SBG) is traditionally used medicinal herb that has anti-oxidant, anticancer and anti-inflammatory effects. In this study, we investigated whether the extracts of SBG have the inhibitory activity in the osteoclast differentiation by using mouse monocytes RAW264.7 cells and primary mouse bone marrow-derived macrophages (BMMs). Methanol extract (ME) from SBG was successively fractionated into methylene chloride (MF), ethylacetate (EF) and n-butanol fraction (BF). The activity assay for tartrateresistant acid phosphatase (TRAP) and Western blot analysis were employed to evaluate the osteoclasts differentiation and the activation of mitogen-activated protein (MAP) kinases, respectively. ME, MF, EF and BF significantly and dose-dependently inhibited osteoclast differentiation without the decrease of cell viability at the concentrations used in this study. In addition, ME significantly inhibited the activation of c-jun-N-terminal kinase (JNK). In conclusion, this study firstly demonstrated that ME of SBG has the potential to inhibit the osteoclast differentiation through the suppression of JNK activation partially.

Keywords

References

  1. Boyle, W.J., Simonet, W.S., and Lacey, D.L., Osteoclast differentiation and activation. Nature 423, 337-342 (2003) https://doi.org/10.1038/nature01658
  2. Choi, J., Conrad, C.C., Malakowsky, C.A., Talent, J.M., Yuan, C.S., and Gracy, R.W., Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines. Biochim. Biophys. Acta. 1571, 201-210 (2002) https://doi.org/10.1016/S0304-4165(02)00217-9
  3. Chung, B.S., Dictionary of Korean folk medicine, Young Lim Sa, Seoul, 1998, pp. 813-814
  4. David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H., and Wagner, E.F., JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 15, 4317-4325 (2002)
  5. Han, K.Y., Yang, D., Chang, E.J., Lee, Y., Huang, H., Sung, S.H., Lee, Z.H., Kim, Y.C., and Kim, H.H., Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem. Pharmacol. 74, 911-923 (2007) https://doi.org/10.1016/j.bcp.2007.06.044
  6. Huang, G.C., Chow, J.M., Shen, S.C., Yang, L.Y., Lin, C.W., and Chen, Y.C., Wogonin but not Nor-wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages. Int. Immunopharmacol. 7, 1054-1063 (2007) https://doi.org/10.1016/j.intimp.2007.04.001
  7. Kim, H.H., Kim, J.H., Kwak, H.B., Huang, H., Han, S.H., Ha, H., Lee, S.W., Woo, E.R., and Lee, Z.H., Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem. Pharmacol. 67, 1647-1656 (2004) https://doi.org/10.1016/j.bcp.2003.12.031
  8. Kim, H.H., Lee, D.E., Shin, J.N., Lee, Y.S., Jeon, Y.M., Chung, C.H., Ni, J., Kwon, B.S., and Lee, Z.H., Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun Nterminal kinase. FEBS Lett. 443, 297-302 (1999) https://doi.org/10.1016/S0014-5793(98)01731-1
  9. Lee, Z.H., Kwack, K., Kim, K.K., Lee, S.H., and Kim, H.H., Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. Mol. Pharmacol. 58, 1536-1545 (2000) https://doi.org/10.1124/mol.58.6.1536
  10. Qiu, S.X., Dan, C., Ding, L.S., Peng, S., Chen, S.N., Farnsworth, N.R., Nolta, J., Gross, M.L., and Zhou, P., A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem. Biol. 14, 860-869 (2007) https://doi.org/10.1016/j.chembiol.2007.06.010
  11. Rodan, G.A. and Martin, T.J., Therapeutic approaches to bone diseases. Science 289, 1508-1514 (2000) https://doi.org/10.1126/science.289.5484.1508
  12. Shim, K.S., Kim, S.N., Kim, M.H., Kim, Y.S., Ryu, S.Y., Min, Y.K., and Kim, S.H., Inhibitory effects of Saururus chinensis extracts on osteoclast differentiation. Nat. Prod. Sci. 14, 113-117 (2008)
  13. Teitelbaum, S.L., Bone resorption by osteoclasts. Science 289, 1504-1508 (2000) https://doi.org/10.1126/science.289.5484.1504
  14. Teitelbaum, S.L. and Ross F.P., Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 8, 638-649 (2003)
  15. Yoo, H.H., Park, J.H., and Kwon, S.W., In vitro cytotoxic activity of some Korean medicinal plants on human cancer cell lines: enhancement in cytotoxicity by heat processing. Phytother. Res. 21, 900-903 (2007) https://doi.org/10.1002/ptr.2213